User menu

Self-treatment of Acute Migraine With Subcutaneous Sumatriptan Using An Auto-injector Device - Comparison With Customary Treatment in An Open, Longitudinal-study

Bibliographic reference Schoenen, J. ; Bulcke, J. ; Caekebeke, J. ; Dehaene, I. ; Dekeyser, J. ; et. al. Self-treatment of Acute Migraine With Subcutaneous Sumatriptan Using An Auto-injector Device - Comparison With Customary Treatment in An Open, Longitudinal-study. In: Cephalalgia : an international journal of headache, Vol. 14, no. 1, p. 55-63 (1994)
Permanent URL http://hdl.handle.net/2078.1/48944
  1. Headache Classification Committee of the International Headache Society, Cephalalgia, 8, 1 (1988)
  2. Peatfield RC, Handbook of clinical neurology, 4, 173 (1980)
  3. Lance JW, Cephalalgia, 9, 7 (1989)
  4. Kimball R. W., Friedman A. P., Vallejo E., Effect of serotonin in migraine patients, 10.1212/wnl.10.2.107
  5. Connor HE, Eur J Pharmacol, 96, 379 (1989)
  6. Humphrey PPA, Cephalalgia, 9, 23 (1989)
  7. Parsons AA, Cephalalgia, 9, 47 (1989)
  8. Buzzi M. Gabriella, Moskowitz Midiael A., The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater, 10.1111/j.1476-5381.1990.tb14679.x
  9. The Oral Sumatriptan Dose-Defining Study Group: sumatriptan., Eur Neurol, 31, 300 (1991)
  10. Tfelt-Hansen P, Cephalalgia, 9, 73 (1969)
  11. The Sumatriptan Auto-Injector Study Group, Eur Neurol, 31, 323 (1991)
  12. Cady Roger K., Treatment of Acute Migraine With Subcutaneous Sumatriptan, 10.1001/jama.1991.03460210077033
  13. Treatment of Migraine Attacks with Sumatriptan : The Subcutaneous Sumatriptan International Study Group*, 10.1056/nejm199108013250504
  14. Soyka D, Med Monatsschr Pharm, 15, 196 (1992)
  15. Ferrari MD, Ned Tijdschr Geneeskd, 137, 850 (1993)